MassachusettsState Snapshot for Effective Treatment
In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.
Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.
|Measure||Recent Year||Recent Rate||Recent Performance||Baseline Year||Baseline Rate||Baseline Performance|
|Lung cancer deaths per 100,000 population per year||2016||37.3||Average||2000||56.2||Average|
|Stroke patients prescribed statin medication at hospital discharge||2015||97.5||Average||2013||95.4||Better than Average|
|Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year||2015||52.3||Average||2013||64.2||Better than Average|
|Persons age 13 and over living with HIV who know their serostatus||2015||85.6||Average||2010||83.1||Average|
|Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment||2015||88.4||Average||2008||82.3||Average|